Hwang et al demonstrated that the IL-6Rα knockdown-DC vaccine significantly enhances the frequency of tumor-specific CD8+ producing effector molecules such as IFN-γ, TNF-α, FasL, perforin, and granzyme B, and generates more memory T cells, resulting in prolonged survival [31]. The gene discussed is PRF1; the disease is neoplasm.